Maynard Um
-
-
-
-
-
-
-
Genmab presents positive EPCORE FL-1 subgroup data for lymphoma treatment
-
-
-
-
-
-
-
Genmab shows safety data for ovarian cancer drug combination
-
-
-
-
-
-
-
Genmab A/S (GMAB) Reports FY EPS of $15.37
-
-
-
-
-
-
-
Genmab A/S (GMAB) halted, news pending
-
-
-
-
-
-
-
Genmab A/S (GMAB) PT Raised to $41 at H.C. Wainwright
-
-
-
-
-
-
-
Genmab A/S (GMAB) PT Raised to $49 at Truist Post MRUS Acquisition
-
-
-
-
-
-
-
Genmab A/S (GMAB) PT Raised to $36 at H.C. Wainwright
-
422,715 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

